Transforming innovation from target to cure. Revvity delivers end-to-end expertise and solutions from research discovery to development, and diagnosis to cure. Our scalable, end-to-end workflows are uniquely positioned to meet your needs – from basic research through to the development of new drugs. Our team introduces roughly 1,500 new life science antibodies, kits and reagents annually and 47 of the world's top 50 pharma companies use our discovery solutions and services to work towards finding novel therapeutics. Learn why here: www.revvity.com
-
Industry
-
Biotechnology Research
-
Company size
-
5,001-10,000 employees